‹ All stocks

Apollomics

APLMW · NASDAQ · Healthcare

$0.01

▼ $0.01 (-16.03%)

1D 7D 1M 3M 1Y All

Day range

$0.01 – $0.01

Year range

$0.01 – $0.23

Open

$0.01

Previous close

—

Market cap

$162.58M

Volume (24h)

$100

Volume (52w)

Performance

▼ -5.17%

▼ -20.29%

▼ -42.11%

▼ -29.49%

▼ -57.69%

YTD

▼ -16.67%

▼ -72.50%

▼ -90.85%

All-time

▼ -90.85%

Key statistics

P/E ratio

0.00

EPS (TTM)

$-307.28

Dividend yield

—

Dividend (TTM)

—

Payout ratio

—

Shares outstanding

14.8B

About Apollomics

Apollomics, Inc. functions as a clinical-phase biotechnology enterprise, concentrating its efforts on discovering and advancing novel cancer treatments to meet crucial, underserved patient requirements. The company was co-founded by Liang Yu Guo and Sanjeev Redkar in 2015, with its main operations based in Foster City, California.

Visit website

Country: United States of America

LLY Eli Lilly and Company	$1149.85	-0.62%
JNJ Johnson & Johnson	$258.66	-2.30%
ABBV AbbVie	$260.03	-0.60%
MRK Merck & Co.	$143.81	-1.03%
UNH UnitedHealth Group Incorp…	$365.20	-0.51%